Cytoscient offers expert services for pharmaceutical and biomarker development. Our goal is to provide high quality data that is cost-effective and rapid for your decision making.
Our extensive experience includes early drug discovery, IND-enabling toxicology, and clinical trials. We know how to characterize new drug candidates, and to confidently translate results at each development stage.
Download Cytoscient’s brochure for more details.
Cytoscient offers attractive discounts to companies in the QB3 network. Available: 30% discount for the first study and 20% off for the first year. A guaranteed 10% discount after one year.